Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

Poster
Topic: Osteoporosis
Abstract number: 26166
MEDICATION USE IN PATIENTS WITH A HIP FRACTURE -DRUG
PRESCRIPTIONS 6 MONTHS BEFORE AND AFTER THE FRACTURE
Annika KRAGH EKSTAM 1 , Sölve ELMSTÅHL 1 , Isam ATROSHI 2
1 Institute of Health, Care and Society, Department of Geriatrics, Clinical Research
Centre, Malmoe University Hospital, Faculty of Medicine, Lund University, Lund,
Kristianstad (SWEDEN), 2 Department of Clinical Sciences, Lund University, Lund
(SWEDEN)
OBJECTIVES: To investigate hip fracture patients´ use of fall-risk increasing drugs
(FRIDs) and bone-density-active medication before and after the fracture and to
analyze possible relationship to gender, age and geographic area. DESIGN:
Population-based cohort study with data retrieved from two national databases.
METHOD: 2043 participants´ >=60 years with a hip fracture during 2006 in a
Swedish county. Medications prescribed within 6 months before and 6 months after
hip fracture. RESULTS: Before the hip fracture 1374 (67%) patients received FRIDs.
Patients aged >=80 years were significantly more likely to receive FRIDs than those
aged 60-79 years; all FRIDs (70% vs 61%), >=5 drugs (51% vs 41%), cardiovascular
drugs (46% vs 37%) and sedatives/hypnotics (38% vs 30%), p=10 and
>=3 psychotropic drugs) was shown. Use of osteoporosis medication increased
minimally, calcium/vitaminD 19% and bisphosphonates 4%. Significant differences in
post fracture prescribing between five health care districts were seen, opioids (85%
vs 65%), bisphosphonates (21% vs 4%) and calcium/vitaminD (72% vs 13%).
CONCLUSIONS: A majority of hip fracture patients were prescribed FRIDs before
fracture and prescribing of FRIDs increased after fracture. There were differences in
prescribing between health care districts and age groups that remains to be
explained.
360